Montenegro vs Serbia: Colon and rectum cancer screening coverage in Europe
Montenegro
22.7%
in 2024
Serbia
7.5%
in 2024
Montenegro rank
17th
Serbia rank
20th
Colon and rectum cancer screening coverage in Europe over time
- Montenegro
- Serbia
How they compare
Montenegro currently reports 22.7% against 7.5% in Serbia, a difference of 15.2%.
That makes Montenegro's figure about 3.0 times Serbia's.
The two have swapped places 2 times across 6 shared years of data; in 2019 it was Montenegro ahead.
Montenegro ranks 17th and Serbia ranks 20th of 20 countries.
Montenegro has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Montenegro | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 23.7% | 5.9% | 17.8% | Montenegro |
| 2020s | 9.7% | 3.6% | 6.1% | Montenegro |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher colon and rectum cancer screening coverage in europe, Montenegro or Serbia?
- Montenegro, at 22.7% against 7.5% in Serbia as of 2024.
- What is the difference in colon and rectum cancer screening coverage in europe between Montenegro and Serbia?
- 15.2%, with Montenegro ahead.
- How many years of comparable data are there for Montenegro and Serbia?
- 6 years are reported by both, from 2019 to 2024.
- How do Montenegro and Serbia rank globally for colon and rectum cancer screening coverage in europe?
- Montenegro ranks 17th and Serbia ranks 20th of 20 countries.
- Where does this data come from?
- Eurostat (2026) – with minor processing by Our World in Data, published as Colon and rectum cancer screening coverage in Europe. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of people aged 50 to 74 years who have been screened for colon and rectum cancer within the previous 2 years.